未登录 分享 收藏
分享 收藏
Feasibility of ctDNA-guided precision neoadjuvant therapy in locally advanced rectal cancer: Insights from the ongoing CINTS-R trial Zhang, Xiao; Zhou, Jiaolin; Geng, Jianhao; Li, Yongheng; Huang, Fei; Shu, Wenlong; Fu, Wei; Zhou, Xin; Wu, Guoju; Jia, Wenzhuo; Cui, Jian; Wang, Zhenjun; Han, Jiagang; Shi, Bohao; Li, Lifeng; Rui, Jinqiu; Xue, Huadan; Hu, Ke; Xu, Tao; Chen, Weijie; Lu, Junyang; Yao, Hongwei; Liu, Qian; Lin, Guole 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Quantitative reconstruction of soil erosion process in a crater lake catchment during the Holocene, Southwest China 中国西南全新世火山口湖流域土壤侵蚀过程的定量重建 Zhao, Hongfei; Zhang, Zhuoya; Zhou, Xin; He, Hongming; Wang, Sen; Jiang, Shiwei; Liu, Xiaoyan; Liu, Xuanqiao; Chen, Anze; Luo, Yong; Kan, Wangyang 分享 收藏
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD 降低剂量化疗后使用blinatumomab治疗新诊断的费城染色体阴性B细胞前体急性淋巴细胞白血病:与hyper-CVAD的倾向评分匹配比较 Lu, Jing; Zhu, Yu; Qiu, Huiying; Wang, Ying; Zhou, Xin; Dai, Haiping; Lu, Xuzhang; Gu, Bin; Hong, Ming; Miao, Miao; Lu, Ruinan; Wang, Jun; Wu, Qian; Xue, Mengxing; Wang, Yun; Deng, Ailing; Shen, Yaoyao; Liu, Yin; Dou, Xueqing; Lei, Yutian; Yang, Xiaofei; Chen, Suning 分享 收藏
分享 收藏
Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study 伊沙佐米为基础的方案作为初治新诊断多发性骨髓瘤患者的中国一线治疗:Infinite研究真实世界数据 Cheng, Fu Cheng; Jin, Song; Zhuang, Junling; Zhou, Xin; Zhou, Fan; Li, Yuhua; Ding, Kaiyang; Niu, Ting; Chen, Wenming; Fang, Baijun; Chen, Li-Li; Fu, Rong; Zhang, Hao; Fu, Jiaping; Wang, Xiuju; Liu, Sha; Li, Lin; Wu, Depei 分享 收藏
Platelet membrane coated r-SAK to improve thrombolytic efficacy by targeting thrombus Hua, R.; Li, M.; Lin, Q.; Dong, M.; Gong, X.; Lin, Z.; Li, Y.; Li, C.; Wu, T.; Wang, Q.; Wu, T.; Zhou, X.; Yang, F.; Li, C. 分享 收藏
分享 收藏
Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial 减少剂量化疗和blinatumomab作为新诊断的Ph阴性b细胞前体急性淋巴细胞白血病的诱导治疗: 一项2期试验 Lu, Jing; Qiu, Huiying; Wang, Ying; Zhou, Xin; Dai, Haiping; Lu, Xuzhang; Yang, Xiaofei; Gu, Bin; Hong, Ming; Miao, Miao; Lu, Ruinan; Wang, Jun; Wu, Qian; Xue, Mengxing; Wang, Yun; Deng, Ailing; Shen, Yaoyao; Liu, Yin; Dou, Xueqing; Lei, Yutian; Wu, Depei; Zhu, Yu; Chen, Suning 分享 收藏
分享 收藏
分享 收藏
A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia orelabrutinib的2期试验在持续性或慢性原发性免疫性血小板减少症患者中显示出良好的疗效和安全性 Yan, Shi; Zhou, Hu; Huang, Ruibin; Wang, Fang; Mei, Heng; Lin, Lie; Guo, Jingming; Zhou, Xin; Li, Zhenyu; Liu, Yaorong; Li, Sichen; Zhou, Wei; Hou, Yu; Hou, Ming 分享 收藏
分享 收藏
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial Toripalimab联合nab-紫杉醇治疗转移性或复发性三阴性乳腺癌: 一项随机3期试验 Jiang, Zefei; Ouyang, Quchang; Sun, Tao; Zhang, Qingyuan; Teng, Yuee; Cui, Jiuwei; Wang, Haibo; Yin, Yongmei; Wang, Xiaojia; Zhou, Xin; Wang, Yongsheng; Sun, Gang; Wang, Jingfen; Zhang, Lili; Yang, Jin; Qian, Jun; Yan, Min; Liu, Xinlan; Yi, Tienan; Cheng, Ying; Li, Man; Zang, Aimin; Wang, Shusen; Wang, Chuan; Wu, Xinhong; Cheng, Jing; Li, Hui; Lin, Ying; Geng, Cuizhi; Gu, Kangsheng; Xie, Chunwei; Xiong, Huihua; Wu, Xiaohong; Yang, Junlan; Li, Qingshan; Chen, Yiding; Li, Fanfan; Zhang, Anqin; Zhang, Yongqiang; Wu, Yudong; Nie, Jianyun; Liu, Qiang; Wang, Kun; Mo, Xueli; Chen, Lilin; Pan, Yueyin; Fu, Peifen; Zhang, Helong; Pang, Danmei; Sheng, Yuan; Han, Yunwei; Wang, Hongxia; Cang, Shundong; Luo, Xianming; Yu, Wenbo; Deng, Rong; Yang, Chaoqiang; Keegan, Patricia 分享 收藏